Steven Romano, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven Romano, M.D.
Steven Romano, M.D. is recorded as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 16, 2024 that Steven Romano, M.D. was appointed Class III director, effective September 16, 2024.
“On September 16, 2024, the Board of Directors (the "Board") of Dianthus Therapeutics, Inc. (the "Company") appointed Steven Romano, M.D. as a Class III director of the Company and as a member of the Science and Technology Committee of the Board (the "S&T Committee"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-16–present
-
Current
2024-09-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dianthus Therapeutics, Inc. /DE/
Other people whose current roles at this company are on record from its filings.
- Marino Garcia CEO, Board Member
- Alison F. Lawton Chairman
- Leon O. Moulder, Jr. Chairman, Board Member
- Ryan Savitz CFO
- Steve Mahoney CFO
- Adam Veness General Counsel
- Edward Carr Chief Accounting Officer
- Anne McGeorge Board Member
- Jonathan Violin Board Member
- Jonathan Violin, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.